Investment Banking for Healthcare
Healthcare businesses — from private clinics and dental chains to MedTech startups and pharmaceutical distributors — command premium valuations when positioned correctly. Superia AI's AI-powered platform connects healthcare sellers with specialised buyers who understand regulatory environments, reimbursement models, and clinical workflows across the Baltic and Nordic markets.
- ✓ Buyer networks spanning healthcare PE, hospital groups, and pharma corporates
- ✓ Regulatory-aware diligence templates for healthcare-specific compliance
Sub-Sectors We Cover
Private Clinics & Dental
Multi-site clinics, dental chains, specialty practices, diagnostics
MedTech & Digital Health
Medical devices, telemedicine, health AI, patient management software
Pharma & Distribution
Generic manufacturing, wholesale distribution, specialty pharma, CRO/CMO
Veterinary & Animal Health
Vet clinic chains, animal pharma, pet care, agri-health
Curious About Your Potential Buyers?
Enter your company website to see matched buyers.
Frequently Asked Questions
Healthcare services typically trade at 8-15x EBITDA depending on scale, payer mix, and regulatory moat. MedTech and digital health companies with SaaS revenue can command higher multiples.
Regulatory compliance (CE marks, medical device registration, pharmacy licences) is a key value driver. Clean regulatory history accelerates diligence and supports premium pricing.
Yes — Nordic hospital groups expanding south, pan-European PE platforms rolling up clinics, and MedTech strategics seeking Baltic development centres are all active.
We ensure data room setup follows GDPR best practices for health data. Patient records never leave the provider; diligence focuses on aggregate metrics and anonymised data.
We work on a success-based model — no retainers or upfront fees. Our advisory partners charge a percentage of the transaction value, aligned with your outcome.